Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anterix (ATEX) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Anterix (ATEX) over the last 12 years, with Q4 2025 value amounting to $14.9 million.

  • Anterix's Accounts Payables rose 6531.25% to $14.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.9 million, marking a year-over-year increase of 6531.25%. This contributed to the annual value of $9.1 million for FY2025, which is 514.42% up from last year.
  • Anterix's Accounts Payables amounted to $14.9 million in Q4 2025, which was up 6531.25% from $14.8 million recorded in Q3 2025.
  • Anterix's 5-year Accounts Payables high stood at $14.9 million for Q4 2025, and its period low was $4.7 million during Q3 2021.
  • In the last 5 years, Anterix's Accounts Payables had a median value of $6.9 million in 2021 and averaged $7.7 million.
  • The largest annual percentage gain for Anterix's Accounts Payables in the last 5 years was 10914.48% (2025), contrasted with its biggest fall of 1459.73% (2025).
  • Over the past 5 years, Anterix's Accounts Payables (Quarter) stood at $6.8 million in 2021, then decreased by 3.35% to $6.6 million in 2022, then grew by 25.24% to $8.2 million in 2023, then grew by 9.71% to $9.0 million in 2024, then soared by 65.31% to $14.9 million in 2025.
  • Its Accounts Payables stands at $14.9 million for Q4 2025, versus $14.8 million for Q3 2025 and $6.6 million for Q2 2025.